Emotional proprioception: Treatment of depression with afferent facial feedback

Journal of Psychiatric Research

Volumn 80, Issue , 2016, Pages 93-96

  Finzi, Eric ^a   Rosenthal, Norman E ^b  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Depression; Emotional proprioception; Facial feedback; Treatment

Indexed keywords

BOTULINUM TOXIN; BOTULINUM TOXIN A; MUSCLE RELAXANT AGENT;

ANGER; ARTICLE; BRAIN FUNCTION; CRANIAL NERVE; DEPRESSION; DISGUST; EMOTIONALITY; FACE MUSCLE; FACIAL EXPRESSION; FACIAL FEEDBACK; FEAR; FEEDBACK SYSTEM; FUNCTIONAL MAGNETIC RESONANCE IMAGING; FUNCTIONAL NEUROIMAGING; HAPPINESS; HUMAN; NEUROANATOMY; PRIORITY JOURNAL; PROPRIOCEPTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); TRIGEMINAL NERVE; DRUG EFFECTS; FEMALE; INNERVATION; MALE; PHOTOSTIMULATION; PHYSIOLOGY; PSYCHOLOGICAL FEEDBACK;

BOTULINUM TOXINS, TYPE A; DEPRESSION; FACIAL EXPRESSION; FACIAL MUSCLES; FEEDBACK, PSYCHOLOGICAL; FEMALE; HUMANS; MALE; NEUROMUSCULAR AGENTS; PHOTIC STIMULATION; PROPRIOCEPTION;

EID: 84975855882     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2016.06.009     Document Type: Article

References (28)

1. Adelmann, P.K., Zajonc, R.B., Facial efference and the experience of emotion. Ann. Rev. Psychol. 40 (1989), 249–280.
2. Cristancho, P., Cristancho, M.A., Baltuch, G.H., Thase, M.E., O'Reardon, J.P., Effectiveness and safety of vagus nerve stimulation for severe treatment-resistant major depression in clinical practice after FDA approval: outcomes at 1 year. J. Clin. Psychiatry 72:10 (2011 Oct), 1376–1382.
3. Cupchik, G.C., Leventhal, H., Consistency between expressive behavior and the evaluation of humorous stimuli: the role of sex and self-observation. J. Pers. Soc. Psychol. 30 (1974), 429–442.
4. Darwin, C., The expression of the emotions in man and animals. Ekman, P., (eds.) Introduction, afterword and commentaries, third ed., 1998, Oxford University Press, London.
5. DeRubeis, R.J., Cognitive therapy vs. medications for depression: treatment outcomes and neural mechanisms. Nat. Rev. Neurosci. 9:10 (2008 October), 788–796.
6. Ekman, P., Levenson, P.W., Friesen, W.V., Autonomic nervous system activity distin-guishes among emotions. Science 4616 (1983), 1208–1210.
7. Finzi, E., The Face of Emotion: How Botox Affects Moods and Relationships. 2013, Palgrave-Macmillan, New York.
8. Finzi, E., Antidepressant effects of botulinum toxin A: scientific rationale. J. Psychiatry Neurosci., 38(5), 2013 Sep, 29.
9. Finzi, E., Rosenthal, N.E., Treatment of depression with onabotulinumtoxinA: a randomized, double-blind, placebo controlled trial. J. Psychiatr. Res. 52 (2014), 1–6.
10. Finzi, E., Wasserman, E., Treatment of depression with botulinum toxin A: a case series. Dermatol. Surg. 32 (2006), 645–649.
11. Heller, A.S., Lapate, R.C., Mayer, K.E., Davidson, R.J., The face of negative affect: trial-by-trial corrugator responses to negative pictures are positively associated with amygdala and negatively associated with ventromedial prefrontal cortex activity. J. Cogn. Neurosci. 26:9 (2014 Sep), 2102–2110.
12. Hennenlotter, A., Dresel, C., Castrop, F., Ceballos-Baumann, A.O., Wohlschläger, A.M., Haslinger, B., The link between facial feedback and neural activity within central circuitries of emotion-new insights from botulinum toxin-induced denervation of frown muscles. Cereb. Cortex 19 (2009), 537–542.
13. Hexsel, D., Brum, C., Siega, C., Schilling-Souza, J., Dal'Forno, T., Heckmann, M., Rodrigues, T.C., Evaluation of self-esteem and depression symptoms in depressed and nondepressed subjects treated with onabotulinumtoxinA for glabellar lines. Dermatol. Surg. 39:7 (2013 Jul), 1088–1096.
14. James, W., The Principles of Psychology. 1890, Holt, New York.
15. Kim, M.J., Neta, M., Davis, F.C., Ruberry, E.J., et al. Botulinum toxin-induced facial muscle paralysis affects amygdala responses to the perception of emotional expressions: preliminary findings from an A-B-A design. Biol. Mood Anxiety Disord., 4, 2014, 11.
16. Laird, J.D., Self-attribution of emotion: the effects of expressive behavior on the quality of emotional experience. J. Pers. Soc. Psychol. 29 (1974), 475–486.
17. Lam, R.W., Levitt, A.J., Levitan, R.D., Michalak, E.E., Cheung, A.H., Morehouse, R., Ramasubbu, R., Yatham, L.N., Tam, E.M., Efficacy of bright light treatment, fluoxetine, and the combination in patients with nonseasonal major depressive disorder: a randomized controlled trial. JAMA Psychiatry 73:1 (2016 Jan 1), 56–63.
18. Larsen, R.J., Kasimatis, M., Frey, K., Facilitating the furrowed brow: an unobtrusive test of the facial feedback hypothesis applied to unpleasant affect. Cognition Emot. 6 (1992), 321–338.
19. Lee, H., Heller, A.S., van Reekum, C.M., Nelson, B., Davidson, R.J., Amygdala-prefrontal coupling underlies individual differences in emotion regulation. Neuroimage 62:3 (2012 Sep), 1575–1581.
20. Magid, M., Reichenberg, J.S., Poth, P.E., Robertson, H.T., LaViolette, A.K., Kruger, T.H., Wollmer, M.A., Treatment of major depressive disorder using botulinum toxin A: a 24-week randomized, double-blind, placebo-controlled study. J. Clin. Psychiatry 75:8 (2014), 837–844.
21. Magid, M., Finzi, E., Kruger, T.H., Robertson, H.T., Keeling, B.H., Jung, S., Reichenberg, J.S., Rosenthal, N.E., Wollmer, M.A., Treating depression with botulinum toxin: a pooled analysis of randomized controlled trials. Pharmacopsychiatry 48:6 (2015 Sep), 205–210.
22. Matsuo, K., Ban, R., Hama, Y., Yuzuriha, S., Eyelid opening with trigeminal proprioceptive activation regulates a brainstem arousal mechanism. PLoS One, 10(8), 2015 Aug 5, e0134659.
23. Niedenthal, P.M., Embodying emotion. Science 316 (2007), 1002–1005.
24. Perry, N., Perry, E., Aromatherapy in the management of psychiatric disorders: clinical and neuropharmacological perspectives. CNS Drugs 20:4 (2006), 257–280.
25. Raglio, A., Attardo, L., Gontero, G., Rollino, S., Groppo, E., Granieri, E., Effects of music and music therapy on mood in neurological patients. World J. Psychiatry 5:1 (2015 Mar 22), 68–78.
26. Ruhé, H.G., Booij, J., Veltman, D.J., Michel, M.C., Schene, A.H., Successful pharmacologic treatment of major depressive disorder attenuates amygdala activation to negative facial expressions: a functional magnetic resonance imaging study. J. Clin. Psychiatry 73:4 (2012 Apr), 451–459.
27. Strack, F., Martin, L.L., Stepper, S., Inhibiting and facilitating conditions of the human smile: a nonobtrusive test of the facial feedback hypothesis. J. Pers. Soc. Psychol. 54:5 (1988), 768–777.
28. Wollmer, M.A., de Boer, C., Kalak, N., Beck, J., Götz, T., Schmidt, T., et al. Facing depression with botulinum toxin: a randomized controlled trial. J. Psychiatr. Res. 46:5 (2012), 574–581.